FDA: Federal Court Enters Consent Decree Against Philips Respironics Following Recall of Certain Sleep Therapy Machines
April 10, 2024
April 10, 2024
WASHINGTON, April 10 -- The U.S. Department of Health and Human Services' Food and Drug Administration issued the following news release on April 3, 2024:
Today, the U.S. District Court for the Western District of Pennsylvania entered a consent decree of permanent injunction against Philips RS North America LLC ("Philips Respironics"), Respironics California LLC, and Philips Holding USA Inc., and Roy Jakobs, CEO of Royal Philips, along with several other individual defenda . . .
Today, the U.S. District Court for the Western District of Pennsylvania entered a consent decree of permanent injunction against Philips RS North America LLC ("Philips Respironics"), Respironics California LLC, and Philips Holding USA Inc., and Roy Jakobs, CEO of Royal Philips, along with several other individual defenda . . .